Cargando…
Multiomic analysis of microRNA-mediated regulation reveals a proliferative axis involving miR-10b in fibrolamellar carcinoma
Fibrolamellar carcinoma (FLC) is an aggressive liver cancer primarily afflicting adolescents and young adults. Most patients with FLC harbor a heterozygous deletion on chromosome 19 that leads to the oncogenic gene fusion, DNAJB1-PRKACA. There are currently no effective therapeutics for FLC. To addr...
Autores principales: | Francisco, Adam B., Kanke, Matt, Massa, Andrew P., Dinh, Timothy A., Sritharan, Ramja, Vakili, Khashayar, Bardeesy, Nabeel, Sethupathy, Praveen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9220943/ https://www.ncbi.nlm.nih.gov/pubmed/35482409 http://dx.doi.org/10.1172/jci.insight.154743 |
Ejemplares similares
-
MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma
por: Dinh, Timothy A., et al.
Publicado: (2019) -
Chemical, Molecular, and Single-nucleus Analysis Reveal Chondroitin Sulfate Proteoglycan Aberrancy in Fibrolamellar Carcinoma
por: Francisco, Adam B., et al.
Publicado: (2022) -
Road map for fibrolamellar carcinoma: progress and goals of a diversified approach
por: Kastenhuber, Edward R, et al.
Publicado: (2019) -
Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells
por: Oikawa, Tsunekazu, et al.
Publicado: (2015) -
Comprehensive microRNA analysis across genome-edited colorectal cancer organoid models reveals miR-24 as a candidate regulator of cell survival
por: Villanueva, Jonathan W., et al.
Publicado: (2022)